{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:31:55Z","timestamp":1782329515446,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.cmi.2017.10.033","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T23:02:09Z","timestamp":1509750129000},"page":"908.e1-908.e7","source":"Crossref","is-referenced-by-count":71,"title":["Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii"],"prefix":"10.1016","volume":"24","author":[{"given":"C.-A.","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-C.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-L.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-L.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-C.","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2017.10.033_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1471-2334-12-200","article-title":"Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program","volume":"12","author":"Kuo","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2017.10.033_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.diagmicrobio.2007.09.006","article-title":"Meropenem activity against European isolates: report on the MYSTIC (meropenem yearly susceptibility test information collection) 2006 results","volume":"60","author":"Turner","year":"2008","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2017.10.033_bib3","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/jac\/dkr239","article-title":"Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006\u201309)","volume":"66","author":"Gales","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.10.033_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nature.2017.21550","article-title":"The drug-resistant bacteria that pose the greatest health threats","volume":"543","author":"Willyard","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cmi.2017.10.033_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/1469-0691.12363","article-title":"Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis","volume":"20","author":"Lemos","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.10.033_bib6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3346\/jkms.2012.27.8.939","article-title":"Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit","volume":"27","author":"Kim","year":"2012","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.cmi.2017.10.033_bib7","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jmii.2014.10.006","article-title":"Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia","volume":"49","author":"Liu","year":"2016","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.cmi.2017.10.033_bib8","series-title":"Annual report of nosocomial infections surveillance system","author":"Center for disease control ROC (Taiwan)","year":"2015"},{"key":"10.1016\/j.cmi.2017.10.033_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-0034-1398388","article-title":"Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options","volume":"36","author":"Doi","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2017.10.033_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.12998\/wjcc.v2.i12.787","article-title":"Antimicrobial resistance in Acinetobacter baumannii: from bench to bedside","volume":"2","author":"Lin","year":"2014","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.cmi.2017.10.033_bib11","series-title":"Food and Drug Administration, USA: FDA drug safety communication: increased risk of death with Tygacil (tigecycline) compared to other antibiotics used to treat similar infections","year":"2010"},{"key":"10.1016\/j.cmi.2017.10.033_bib12","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria","volume":"33","author":"Evans","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cmi.2017.10.033_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijantimicag.2014.01.016","article-title":"Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia","volume":"43","author":"Khawcharoenporn","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2017.10.033_bib14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1590\/S1517-838246420140101","article-title":"Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii","volume":"46","author":"Temocin","year":"2015","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.cmi.2017.10.033_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s15010-013-0495-y","article-title":"Comparison of colistin and colistin\/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia","volume":"42","author":"Kalin","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2017.10.033_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/dkw377","article-title":"Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis","volume":"72","author":"Zusman","year":"2017","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2017.10.033_bib17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.cmi.2017.10.033_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.10.033_bib19","series-title":"European committee on antimicrobial susceptibility testing","author":"Breakpoint tables for interpretation of MICs and zone diameters [Internet]","year":"2016"},{"key":"10.1016\/j.cmi.2017.10.033_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.cmi.2017.10.033_bib21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2017.10.033_bib22","series-title":"The Sanford guide to antimicrobial therapy","author":"David","year":"2016"},{"key":"10.1016\/j.cmi.2017.10.033_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijantimicag.2015.11.011","article-title":"Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis","volume":"47","author":"Ni","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2017.10.033_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2334-14-102","article-title":"Effectiveness of tigecycline-based versus colistin-based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis","volume":"14","author":"Chuang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2017.10.033_bib25","doi-asserted-by":"crossref","first-page":"17091","DOI":"10.1038\/srep17091","article-title":"Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cmi.2017.10.033_bib26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bjid.2012.10.029","article-title":"Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis","volume":"17","author":"Chu","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.cmi.2017.10.033_bib27","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/MJT.0b013e3182a32df3","article-title":"Treatment of carbapenem-resistant acinetobacter baumannii ventilator-associated pneumonia: retrospective comparison between intravenous colistin and intravenous ampicillin-sulbactam","volume":"23","author":"Zalts","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.cmi.2017.10.033_bib28","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1128\/AAC.01406-06","article-title":"Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains","volume":"51","author":"Lo-Ten-Foe","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.10.033_bib29","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17306286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17306286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T21:01:30Z","timestamp":1564693290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X17306286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1198743X17306286"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2017.10.033","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}